BERNA ERİTEN, SERDAR MENEKSE
Annals of Clinical and Analytical Medicine - 2024;15(10):734-738
Aim: Benign tumors and pseudotumoral lesions of the femur can significantly affect the quality of life of patients. This study aims to examine the epidemiologic characteristics of these lesions, treatment approaches, clinical outcomes and how these outcomes are reflected in clinical practice. Material and methods: Between 2010 and 2023, 177 patients diagnosed with benign tumors or pseudotumoral lesions of the femur at Adana Seyhan State Hospital were retrospectively reviewed. The retrospective nature of the study and the statistical methods used (chi-square test) are summarized. Patients were classified according to age groups (0-20, 21-40, 41-60, 61+) and tumor types. Demographic characteristics, tumor localization, treatment modalities, complications and recurrence rates were evaluated. Results: The most common tumor type was osteoid osteoma (n=37, 20.9%). The majority of tumors were seen in the 0-20 age group (n=66, 37.3%) and were more common in males (55.4%, p<0.05). Osteoid osteoma was localized in the femoral shaft in 59.5% of cases. The most common treatment modality was radiofrequency ablation (64.9%). The overall recurrence rate was 8.5%, the highest recurrence rate was observed in giant cell tumors (15.6%), the clinical significance of these rates should be emphasized. Discussion: The study has proved the way benign tumors and pseudo tumoral lesions are distributed in femur with respect to age, sex, site of the tumor, how these distributions influence trends of treatments, probability of recurrence and their implications for clinical practice. The results highlight the significance of variables including age, sex and site in managing these tumours.
